116834-64-1 Usage
General Description
4-[(8-quinolinylsulfonyl)amino]benzoic acid is a chemical compound with the molecular formula C19H14N2O4S. It is a member of the sulfonamide family and contains a benzoic acid core with a quinoline group attached. 4-[(8-QUINOLINYLSULFONYL)AMINO]BENZOIC ACID is used in the synthesis of pharmaceuticals, including antimalarial and antiviral drugs. It has also been studied for its potential anti-inflammatory and antitumor properties. The presence of the quinoline group in 4-[(8-quinolinylsulfonyl)amino]benzoic acid makes it a versatile molecule with potential applications in diverse fields such as medicine, agriculture, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 116834-64-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,6,8,3 and 4 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 116834-64:
(8*1)+(7*1)+(6*6)+(5*8)+(4*3)+(3*4)+(2*6)+(1*4)=131
131 % 10 = 1
So 116834-64-1 is a valid CAS Registry Number.
116834-64-1Relevant articles and documents
CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL) PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE
-
, (2019/06/11)
Provided herein are amorphous and crystalline hemisulfate salt forms of the formula (I). Also provided are pharmaceutical compositions comprising the amorphous and crystalline hemisulfate salt forms, methods for their manufacture, and uses thereof for tre
Methods of using pyruvate kinase activators
-
, (2016/08/23)
Described herein are methods for using compounds that activate pyruvate kinase.
THERAPEUTIC COMPOUNDS AND COMPOSITIONS
-
Paragraph 0463, (2014/09/30)
Compounds of general formula I: and compositions comprising compounds of general formula I that modulate pyruvate kinase are described herein. Also described herein are methods of using the compounds that modulate pyruvate kinase in the treatment of diseases.
